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Abstract During a 3-year period, 848 patients were detected
as carriers of methicillin-resistant Staphylococcus aureus
(MRSA) by the Xpert MRSA assay (Cepheid). Among them,
108 patients (12.7 %) were colonized with strains showing
methicillin-susceptible phenotypes and absence of the mecA
gene, despite being positive with the rapid polymerase chain
reaction (PCR) assay. DNA sequences of the staphylococcal
cassette chromosome mec (SCCmec) insertion site of these
“false-positive” strains was determined by direct sequencing
of the genomic DNA. More than half (53.7 %) of the strains
had DNA sequences unrelated to either SCC or SCCmec and
one-third had DNA sequences related to non-mec SCC. Only
10.2 % of the strains carried sequences related to SCCmec,
suggesting that a sequence containing the mecA gene was lost
from an SCCmec. These findings differ from the general idea
that all methicillin-susceptible S. aureus having positive Xpert
MRSA assay results are essentially MRSA that lost the mecA
gene.
Introduction
Methicillin-resistant Staphylococcus aureus (MRSA) is one of
the leading causes of hospital-acquired infections and is asso-
ciated with a high mortality rate. Patients with MRSA infec-
tions have prolonged length of stay in hospitals, which results
in higher costs of hospitalization [1–4]. With this perspective,
surveillance programs play an important role in preventing
onward transmission from carriers, resulting in a decreased
risk of infection for other patients and reduced economic
impact for the hospital. Over the last decade, standard culture
techniques have been replaced by more rapid molecular
methods to detect MRSA in clinical samples.
Broad-spectrum resistance to β-lactam antibiotics is
encoded by the mecA gene, which is located on the
staphylococcal cassette chromosome mec (SCCmec), a
genomic island inserted at the 3′ end of the rlmH gene
(previously named orfX) [5]. Several commercially avail-
able polymerase chain reaction (PCR)-based kits detect
the junction formed upon the insertion of SCCmec in the
chromosome, using primers located in the conserved rlmH
gene and several primers and probes detecting different
SCCmec types. This rapid detection of MRSA-positive
samples within a few hours might have an important
impact on MRSA surveillance [6, 7]. However, since their
introduction as tools for surveillance and diagnosis, a
number of studies have shown that misinterpretation can
often occur [8–14]. In a pilot study aiming to detect the
chromosome–SCCmec junction by PCR, a false-positive
signal was found in 26 strains (4.6 %) in a collection of
569 methicillin-sensitive S. aureus (MSSA) [15]. A more
recent study showed that, among 251 Xpert MRSA-
positive samples obtained during a 1-year period, 23
(9.2 %) were MSSA isolates [16]. Similarly, a 9-month
study conducted in our hospital showed that, among 217
patients with a positive Xpert MRSA assay, 28 (12.9 %)
were colonized by an MSSA isolate [8].
In this study, we characterized the SCCmec insertion
site in 108 strains misidentified as MRSA by the Xpert
MRSA assay (GeneXpert system, Cepheid, Sunnyvale,
CA) during a 3-year period using direct sequencing of
genomic DNA.
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Materials and methods
Bacterial strains
The University Hospital of Lausanne is a 1,000-bed tertiary
care hospital where active surveillance cultures are part of its
MRSA control program. The rapid PCR-based Xpert MRSA
assay was introduced in June 2009 for MRSA screening. The
detection and sampling methods have been described previ-
ously [17]. When a discrepant result was obtained, i.e., posi-
tive Xpert MRSA assay and absence of typical pink colonies
on MRSASelect agar plates (Bio-Rad, Marnes-la-Coquette,
France), the strain was tested on a chromogenic S. aureus agar
plate (SAID, bioMérieux, Marcy-l′Etoile, France). If S. aureus
characteristic green colonies grew on this plate, an Xpert
MRSA assay was performed on the colonies and, if positive,
the resistance to methicillin was assessed by an antibiogram
using the Kirby–Bauer method with cefoxitin (30 μg) and
oxacillin (1 μg) disks. Absence of the mecA gene was con-
firmed by PCR with a previously described method [18]. The
presence of ccrAB genes was detected by M-PCR1 (as de-
scribed by Kondo et al. [18]). Genotyping of all strains was
performed by multilocus sequence typing (MLST) and
double-locus sequence typing (DLST), as previously de-
scribed [19–21].
Genomic DNA extraction
Genomic DNAwas extracted using a protocol described pre-
viously [22]. In brief, 3 mL of an overnight culture were
centrifuged and resuspended in 50 μL of lysostaphin solution
(10 mM Tris-Cl, pH 7.5, and 1 mM EDTA, supplemented
with lysostaphin at a final concentration of 0.5 μg/mL). After
30 min of incubation at 37 °C, 300 μL of “Nuclei Lysis
Solution” (Promega Corporation, Madison, WI) were added
and the cell suspensions were heated at 80 °C for at least
10 min. The samples were then cooled at room temperature
and treated with RNase. Subsequently, 100 μL of “Protein
Precipitation Solution” (Promega Corporation) were added to
the samples, which were then incubated for 5 min on ice. After
centrifugation (4 °C, 15,600×g), supernatants were discarded
and 300 μL of isopropanol were used to precipitate the DNA,
which was then washed with 70 % ethanol and pelleted by
centrifugation. DNA samples were then air-dried and re-
diluted at 4 °C overnight in 20 μL of nuclease-free H2O.
DNA concentrations and qualities were determined using an
ND-1000 Spectrophotometer (NanoDrop Technologies, Wil-
mington, DE).
DNA sequencing and data treatment
Highly concentratedDNAwas required for the direct sequenc-
ing of genomic DNA, between 2 and 3 μg/μL. The
sequencing reaction was performed with 2 μL of DNA, using
the BigDye Terminator v.1.1 Sequencing Kit (Applied
Biosystems, Foster City, CA), following the protocol of the
manufacturer. Sequencing was performed using an ABI
PRISM 3730 DNA Analyzer (Applied Biosystems). Two
primers binding in conserved regions of the rlmH gene were
used for genomic sequencing. The seql_fw primer (CGTTTA
GGCCCATACACCAAGATAGAC, starting at position +76
of the rlmH gene) was used in the first instance. A second
primer, seq2_fw (CGCAGTAACTACGCACTATCATTCAG
C, starting at position +357 of the rlmH gene), was used when
the sequence obtained with the first primer was too short.
Sequencing data were analyzed by Geneious software
v7.0.6 (Biomatters Ltd., Auckland, New Zealand). An aver-
age read length of 685 bp was obtained, with an average
phred40 (99.99 % base call accuracy) quality of 82.8 %.
Nucleotide sequence accession numbers
The DNA sequences surrounding the SCCmec insertion sites
of one representative strain per sequence group have been
deposited in GenBank. The accession numbers are as follows:
KJ786840 for strain H26280 (Group 1), KJ786841 for strain
H21732 (Group 2), KJ786842 for strain H22446 (Group 3),
KJ786843 for strain H25130 (Group 4), KJ786844 for strain
H22311 (Group 5), KJ786845 for strain H25652 (Group 6),
KJ786846 for strain H24478 (Group 7), KJ786847 for strain
H24884 (Group 8), KJ786848 for strain H24314 (Group 9),
KJ786849 for strain H23280 (Group 10), KJ786850 for strain
H27390 (Group 11), KJ786851 for strain H22887 (Group 12),
KJ786852 for strain H27608 (Group 13), KJ786853 for
strain H26736 (Group 14), KJ786854 for strain H21876
(Group 15), KJ786855 for strain H25653 (Group 16),
KJ786856 for s t ra in H25356 (Group 17) , and
KJ786857 for strain H24924 (Group 18).
Results
Between July 2010 and June 2013, 848 patients had at least
one screening sample detected as being positive by the Xpert
MRSA assay. Among them, 108 patients (12.7 %) were
colonized by S. aureus isolates which did not contain the
mecA gene.
Sequences downstream of the rlmH gene were determined
by sequencing directly the genomic DNA and aligned to
GenBank/EMBL DNA sequences databases using the
BLAST program [23]. Table 1 shows the different groups of
sequences and their closest matches obtained with BLAST
analysis. Eighteen different groups of sequences were found,
highlighting the great diversity of the genetic content down-
stream of the SCCmec insertion site, as previously described
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Table 1 Characterization of the staphylococcal cassette chromosome mec (SCCmec) insertion site of methicillin-susceptible Staphylococcus aureus
(MSSA) strains misidentified as methicillin-resistant S. aureus (MRSA) by the Xpert MRSA polymerase chain reaction (PCR) assay
Group ST CC Number of
isolates
Accession
number
BLAST result Sequence
identity
Notes
SCC-unrelated sequences: 53.7 %
1 ST1, ST3,
ST81
CC15 40 KJ786840 S. aureus strain 15575,
SCCmec insertion site
genomic sequence
100 % Genomic sequence
downstream rlmH encoding
a putative transposase and
enterotoxin [24]
2 ST59, ST97,
ST425
CC59, CC97 6 KJ786841 S. aureus LGA251,
complete genome
sequence
99 % Genomic sequence
downstream type XI
SCCmec containing a
putative restriction-
modification system
3 ST59, ST718 CC59 4 KJ786842 S. aureus strain 15585,
SCCmec insertion site
genomic sequence
100 % Genomic sequence
downstream rlmH encoding
unknown proteins [24]
4 ST22 CC22 4 KJ786843 S. aureus isolate
CMFT503, SCCmec
region
100 % Genomic sequence
downstream type IV
SCCmec containing a
putative restriction-
modification system
5 ST1278 CC15 2 KJ786844 S. aureus isolate
CMFT503, SCCmec
region
89 % Genomic sequence
downstream type IV
SCCmec containing a
putative restriction-
modification system
6 ST188 CC15 1 KJ786845 S. aureus strain 15682,
SCCmec insertion site
genomic sequence
100 % Genomic sequence
downstream rlmH encoding
a putative restriction-
modification system [24]
7 ST1094 1 KJ786846 S. aureus ECT-R complete
genome sequence
99 % Genomic sequence encoding
IS1181 transposase
SCC-related sequences: 33.3 %
8 ST8 CC8 18 KJ786847 S. aureus isolate
CMFT535, SCCmec
region
99 % SCC element carrying type 1
ccrAB genes encoding a
putative restriction-
modification system
9 ST78, ST88,
ST129
CC88 11 KJ786848 S. haemolyticus JCSC1435,
complete genome
sequence
93 % ΨSCC encoding unknown
proteins
10 ST30, ST852 CC22, CC30 3 KJ786849 S. aureus strain 15580,
SCCmec insertion site
genomic sequence
99 % ΨSCC encoding putative
transposases
11 ST1, ST5 CC5, CC15 2 KJ786850 S. aureus strain
WAMRSA40 SCCmec
genomic sequence
100 % ΨSCC containing pls gene
12 ST5 CC5 2 KJ786851 S. aureus strain
USA300_R114
SCCmec IVa andACME
sequences
97 % Identity to parts of the ACME
element in strain
USA300_R114
SCCmec-related sequences: 10.2 %
13 ST5, ST8,
ST45,
ST125
CC5, CC8,
CC45
8 KJ786852 Several MRSA strains 100 % Several strains carrying type II
or type IV SCCmec
14 ST45 CC45 1 KJ786853 Several MRSA strains 100 % Several strains carrying type
III or type V SCCmec
15 ST1 CC15 1 KJ786854 S. aureus strain LG1-053
genomic sequence
100 % SCCmecN1
16 ST7 1 KJ786855 S. aureus strain RN7170 95 % J1 region of type II.4 SCCmec
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[24].More than half of all sequences (53.7 %) were not related
to SCC elements in general (i.e., presence of sequences in
which ccr recombinase genes are absent) and SCCmec in
particular (i.e., absence of mecA and ccr genes). Thirty-
seven percent of the strains belonged to the 15575 type (Group
1, Table 1), which is a previously described MSSA associated
with a positive Xpert MRSA assay [14, 24]. Even with the
absence of an SCC cassette, these strains showed high se-
quence identity with the 5′ ends of SCCmec types II or IV, thus
explaining the positive result of the Xpert MRSA assay [14].
All strains of the 15575 group belonged to the same clonal
complex (CC15, Table 1), indicating clonal dissemination,
rather than the presence of a hypothetical mobile genetic
element at this chromosomal site. Four other groups (Groups
2, 4, 5, and 6, Table 1) of SCC-unrelated sequences suggested
the presence of putative restriction-modification systems,
whose presence was previously described in this region of
the chromosome [24].
One-third (36) of the isolates was associated to SCC-
related elements. Among them, 18 strains (16.7 %) showed
100 % identity with an SCC element carrying ccrAB1 genes
(Table S1) and a putative restriction-modification system from
strain CMFT535. Eleven strains (10.2 %) carried a DNA
segment closely related to a ΨSCC (SCC without ccr genes)
from Staphylococcus haemolyticus strain JCSC1435
encoding unknown proteins. The remaining strains in this
group were associated to other ΨSCC or parts of an ACME
element (Table 1).
Only 10.2 % of the strains carried sequences that were
associated with the presence of SCCmec (Table 1). Seven
strains had the same genotype of local MRSA clones
known to carry type IV SCCmec (DLST 3-3, ST 8-IV;
DLST 1-52, ST 45-IV; DLST 4-36, ST 125-IV) and had
sequences that matched with several type IV SCCmec
present in the databases. This was also true for one strain
carrying type II SCCmec (DLST 2-23, ST 5-II). Two
strains had infrequent genotypes and carried sequences
related to type II and type III/V SCCmec, respectively.
One strain had 100 % identity sequence with that of
SCCmecN1 from S. aureus LG1-053.
The remaining three strains (2.8 %) showed no identity to
sequences present in the GenBank/EMBL DNA sequences
databases.
Discussion
We characterized the SCCmec insertion site in 108 iso-
lates that were misidentified as MRSA by the Xpert
MRSA assay. Our findings indicate that this chromosom-
al region is highly diverse among isolates. Surprisingly,
more than half of the strains were not associated to SCC
or SCCmec sequences and one-third carried non-mec
SCC-related sequences. Our results suggests that dropout
of the mecA gene could have occurred in only 10.2 % of
the strains. This observation is in disagreement with the
general idea that MSSA which had a positive result with
the Xpert MRSA assay are essentially strains that lost the
mecA gene.
Although the clonal spread of some STs could account for
these false-positive results (Group 1, ST1; Group 8, ST 8), the
fact that different DLST types were observed strongly suggest
that this dissemination is not solely local.
The genomic structure of SSCs is complex and, despite
many recent next-generation sequencing studies on MRSA,
we are still not able to have a clear picture of these mobile
genetic elements. Moreover, little is known on SCCs that do
not contain the mecA gene. Our results suggest that they are
genetically diverse and more frequent than previously
thought.
In order to improve rapid PCR-based assays for
MRSA screening, further studies are needed in order to
investigate the diversity, dissemination, and prevalence
of such elements. In the meantime, the results from rapid
PCR-based tests should be confirmed by conventional
culture methods.
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Table 1 (continued)
Group ST CC Number of
isolates
Accession
number
BLAST result Sequence
identity
Notes
Unknown sequences: 2.9 %
17 ST45 ST45 2 KJ786856 Unknown type 1 - No matches with GenBank/
EMBL DNA sequences
databases
18 ST34 CC30 1 KJ786857 Unknown type 2 - No matches with GenBank/
EMBL DNA sequences
databases
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